Default company panoramic image


Cognitive decline is the most dramatically unmet medical need of our time...And the most dramatically unrealized investment opportunity.

  • Stage Concept Only
  • Industry Biotechnology
  • Location Los Angeles, CA, USA
  • Currency USD

Company Summary

Promentia has developed proprietary formulations that efficiently deliver efficacious nutrients (for the first time in the history of natural supplements) to the brain. Promentia's world class researchers survey the global marketplace of neuroprotective nutritional supplements and design proprietary blends of nutrients formulated for optimum absorption and efficacy that slow and prevent age-related cognitive decline often leading to Alzheimer's.


  • Default avatar
    Gilbert M Rishton
    Scientific Advisor

    Director, Channel Islands Alzheimer's Institute. Co-Founder and Chief Chemistry Advisor, Cognition Therapeutics. CSO, Cardax Pharma. Acelot, Santa Barbara, Chemistry Advisor, Amgen, Thousand Oaks, CA, Research Scientist, Medicinal Chemistry. UC Irvine, post-doc, Organic Chemistry.